Microbiology & Infectious Diseases

New study shows oral microbiome imbalance and reduced salivary hypotaurine may contribute to neuroinflammation in relapsing-remitting MS.

EACS 2025 study shows doxycycline prophylaxis reduced chlamydia and syphilis rates in Swiss men with HIV, with no effect against gonorrhoea.

EACS 2025 data show over half of HIV diagnoses among migrants in Switzerland occur post-migration, highlighting need for targeted testing and prevention.

EACS 2025 study shows minimal HBV reactivation after stopping tenofovir in people with HIV, supporting safe use of tenofovir-sparing ART.

New EACS data show once-weekly islatravir and lenacapavir maintain HIV viral suppression for 96 weeks with no resistance or major side effects.

A new near point-of-care malaria diagnostic detects low-density infections in 45 minutes, supporting malaria elimination efforts across Africa.

Trace-positive sputum identifies a high-risk group for tuberculosis in Uganda. Chest x-ray abnormalities further highlight patients needing early treatment or monitoring.

Cefiderocol shows comparable effectiveness to standard care in treating carbapenem-resistant bloodstream infections, offering hope against superbugs.